Universal Health Realty Income Trust (UHT) Q3 2024 earnings summary

Executive summary

• Net income for Q3 2024 was $4.0 million ($0.29 per diluted share), up from $3.9 million ($0.28 per diluted share) in Q3 2023; nine-month net income rose to $14.6 million ($1.05 per diluted share) from $11.8 million ($0.85 per diluted share) year-over-year.

• Revenues for Q3 2024 increased 1.1% to $24.5 million; nine-month revenues grew 4.4% to $74.4 million.

• Funds from operations (FFO) for Q3 2024 were $11.3 million ($0.82/share), up from $11.2 million ($0.81/share) in Q3 2023; nine-month FFO was $36.1 million ($2.61/share), up from $33.2 million ($2.40/share) year-over-year.

• Portfolio includes 76 real estate investments across 21 states, with significant exposure to healthcare facilities.

Financial highlights

• Lease revenue from UHS facilities was $8.2 million in Q3 2024; non-related parties contributed $14.3 million.

• Interest expense increased to $4.8 million in Q3 2024 from $4.5 million in Q3 2023, mainly due to higher average borrowings and rates.

• Depreciation and amortization for Q3 2024 was $7.0 million.

• Dividends paid in the nine months ended September 30, 2024 totaled $30.2 million ($2.185/share); Q3 2024 dividend was $0.73 per share ($10.1 million total).

Outlook and guidance

• Management expects sufficient capital resources for the next twelve months, including funding for operations, investments, and dividends.

• No shares were issued under the new $100 million shelf registration as of September 30, 2024.

• Management notes that rising interest rates have increased borrowing costs and could further impact future results and capital market access.

• Ongoing macroeconomic and healthcare industry trends, including staffing shortages and regulatory changes, may materially affect tenant and trust performance.